Upregulation of myocardial and vascular phosphodiesterase 9A in a model of atherosclerotic cardiovascular disease

Daniel Priksz, Mariann Bombicz, Balazs Varga, Andrea Kurucz, R. Gesztelyi, Jozsef Balla, Attila Toth, Z. Papp, Z. Szilvássy, B. Juhász

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Atherosclerosis is strongly associated with cardiac dysfunction and heart failure. Besides microvascular dysfunction and diminishment of the cardiac nitric oxide-Protein Kinase G (NO-PKG) pathway, recent evidence suggests that phosphodiesterase 9A (PDE9A) enzyme has an unfavorable role in pathological changes. Here, we characterized a rabbit model that shows cardiac dysfunction as a result of an atherogenic diet, and examined the myocardial PDE9A signaling. Rabbits were divided into Control (normal diet) and HC (atherogenic diet) groups. Cardiac function was evaluated by echocardiography. Vascular function was assessed, along with serum biomarkers. Histological stains were conducted, expression of selected proteins and cyclic guanosine monophosphate (cGMP) levels were determined. Signs of diastolic dysfunction were shown in HC animals, along with concentric hypertrophy and interstitial fibrosis. Endothelial function was diminished in HC rabbits, along with marked reduction in the aortic lumen, and increased left ventricle outflow tract (LVOT) pressures. A significant increase was shown in myocardial PDE9A levels in HC animals with unchanged vasodilator-stimulated phosphoprotein (VASP) phosphorylation and cGMP levels. Upregulation of PDE9A may be associated with early stage of cardiac dysfunction in atherosclerotic conditions. Since PDE9A is involved in cGMP degradation and in deactivation of the cardioprotective PKG signaling pathway, it may become an encouraging target for future investigations in atherosclerotic diseases.

Original languageEnglish
Article number2882
JournalInternational Journal of Molecular Sciences
Volume19
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

guanosines
diets
rabbits
Phosphoric Diester Hydrolases
Nutrition
Blood Vessels
Cardiovascular Diseases
Up-Regulation
Cyclic GMP
animals
Atherogenic Diet
Animals
proteins
Proteins
arteriosclerosis
echocardiography
Echocardiography
fibrosis
phosphorylation
Rabbits

Keywords

  • Atherosclerosis
  • Cardiac dysfunction
  • Echocardiography
  • Endothelial dysfunction
  • Phosphodiesterase 9A
  • Rabbit model

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Upregulation of myocardial and vascular phosphodiesterase 9A in a model of atherosclerotic cardiovascular disease. / Priksz, Daniel; Bombicz, Mariann; Varga, Balazs; Kurucz, Andrea; Gesztelyi, R.; Balla, Jozsef; Toth, Attila; Papp, Z.; Szilvássy, Z.; Juhász, B.

In: International Journal of Molecular Sciences, Vol. 19, No. 10, 2882, 01.10.2018.

Research output: Contribution to journalArticle

@article{48c2ea34684649f5af3b811315f6d47f,
title = "Upregulation of myocardial and vascular phosphodiesterase 9A in a model of atherosclerotic cardiovascular disease",
abstract = "Atherosclerosis is strongly associated with cardiac dysfunction and heart failure. Besides microvascular dysfunction and diminishment of the cardiac nitric oxide-Protein Kinase G (NO-PKG) pathway, recent evidence suggests that phosphodiesterase 9A (PDE9A) enzyme has an unfavorable role in pathological changes. Here, we characterized a rabbit model that shows cardiac dysfunction as a result of an atherogenic diet, and examined the myocardial PDE9A signaling. Rabbits were divided into Control (normal diet) and HC (atherogenic diet) groups. Cardiac function was evaluated by echocardiography. Vascular function was assessed, along with serum biomarkers. Histological stains were conducted, expression of selected proteins and cyclic guanosine monophosphate (cGMP) levels were determined. Signs of diastolic dysfunction were shown in HC animals, along with concentric hypertrophy and interstitial fibrosis. Endothelial function was diminished in HC rabbits, along with marked reduction in the aortic lumen, and increased left ventricle outflow tract (LVOT) pressures. A significant increase was shown in myocardial PDE9A levels in HC animals with unchanged vasodilator-stimulated phosphoprotein (VASP) phosphorylation and cGMP levels. Upregulation of PDE9A may be associated with early stage of cardiac dysfunction in atherosclerotic conditions. Since PDE9A is involved in cGMP degradation and in deactivation of the cardioprotective PKG signaling pathway, it may become an encouraging target for future investigations in atherosclerotic diseases.",
keywords = "Atherosclerosis, Cardiac dysfunction, Echocardiography, Endothelial dysfunction, Phosphodiesterase 9A, Rabbit model",
author = "Daniel Priksz and Mariann Bombicz and Balazs Varga and Andrea Kurucz and R. Gesztelyi and Jozsef Balla and Attila Toth and Z. Papp and Z. Szilv{\'a}ssy and B. Juh{\'a}sz",
year = "2018",
month = "10",
day = "1",
doi = "10.3390/ijms19102882",
language = "English",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Upregulation of myocardial and vascular phosphodiesterase 9A in a model of atherosclerotic cardiovascular disease

AU - Priksz, Daniel

AU - Bombicz, Mariann

AU - Varga, Balazs

AU - Kurucz, Andrea

AU - Gesztelyi, R.

AU - Balla, Jozsef

AU - Toth, Attila

AU - Papp, Z.

AU - Szilvássy, Z.

AU - Juhász, B.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Atherosclerosis is strongly associated with cardiac dysfunction and heart failure. Besides microvascular dysfunction and diminishment of the cardiac nitric oxide-Protein Kinase G (NO-PKG) pathway, recent evidence suggests that phosphodiesterase 9A (PDE9A) enzyme has an unfavorable role in pathological changes. Here, we characterized a rabbit model that shows cardiac dysfunction as a result of an atherogenic diet, and examined the myocardial PDE9A signaling. Rabbits were divided into Control (normal diet) and HC (atherogenic diet) groups. Cardiac function was evaluated by echocardiography. Vascular function was assessed, along with serum biomarkers. Histological stains were conducted, expression of selected proteins and cyclic guanosine monophosphate (cGMP) levels were determined. Signs of diastolic dysfunction were shown in HC animals, along with concentric hypertrophy and interstitial fibrosis. Endothelial function was diminished in HC rabbits, along with marked reduction in the aortic lumen, and increased left ventricle outflow tract (LVOT) pressures. A significant increase was shown in myocardial PDE9A levels in HC animals with unchanged vasodilator-stimulated phosphoprotein (VASP) phosphorylation and cGMP levels. Upregulation of PDE9A may be associated with early stage of cardiac dysfunction in atherosclerotic conditions. Since PDE9A is involved in cGMP degradation and in deactivation of the cardioprotective PKG signaling pathway, it may become an encouraging target for future investigations in atherosclerotic diseases.

AB - Atherosclerosis is strongly associated with cardiac dysfunction and heart failure. Besides microvascular dysfunction and diminishment of the cardiac nitric oxide-Protein Kinase G (NO-PKG) pathway, recent evidence suggests that phosphodiesterase 9A (PDE9A) enzyme has an unfavorable role in pathological changes. Here, we characterized a rabbit model that shows cardiac dysfunction as a result of an atherogenic diet, and examined the myocardial PDE9A signaling. Rabbits were divided into Control (normal diet) and HC (atherogenic diet) groups. Cardiac function was evaluated by echocardiography. Vascular function was assessed, along with serum biomarkers. Histological stains were conducted, expression of selected proteins and cyclic guanosine monophosphate (cGMP) levels were determined. Signs of diastolic dysfunction were shown in HC animals, along with concentric hypertrophy and interstitial fibrosis. Endothelial function was diminished in HC rabbits, along with marked reduction in the aortic lumen, and increased left ventricle outflow tract (LVOT) pressures. A significant increase was shown in myocardial PDE9A levels in HC animals with unchanged vasodilator-stimulated phosphoprotein (VASP) phosphorylation and cGMP levels. Upregulation of PDE9A may be associated with early stage of cardiac dysfunction in atherosclerotic conditions. Since PDE9A is involved in cGMP degradation and in deactivation of the cardioprotective PKG signaling pathway, it may become an encouraging target for future investigations in atherosclerotic diseases.

KW - Atherosclerosis

KW - Cardiac dysfunction

KW - Echocardiography

KW - Endothelial dysfunction

KW - Phosphodiesterase 9A

KW - Rabbit model

UR - http://www.scopus.com/inward/record.url?scp=85053840810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053840810&partnerID=8YFLogxK

U2 - 10.3390/ijms19102882

DO - 10.3390/ijms19102882

M3 - Article

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 10

M1 - 2882

ER -